SENS, Circulars and Notices

30th June 2022 – Sabcap acquires an interest in Halewood South Africa

29th June 2022 – Availability of BBBEE compliance report

27th June 2022 – Termination of Sabcap’s proposed indirect investment in Ascendis Medical through Apex

7th June 2022 – Dealings in Sabcap shares by an associate of a director

7th June 2022 – Dealings in Sabcap shares by a director

6th June 2022 – Dealings in Sabcap shares by a director

30th May 2022 – Report on proceedings at the annual general meeting

26th April 2022 – Sabcap’s proposed indirect investment in ARB through MEH and Masimong

7th April 2022 – Dealings in Sabcap shares by a prescribed officer

1st April 2022 – Dealings in Sabcap shares by a prescribed officer

31st March 2022 – No Change Statement and Notice of Annual General Meeting

17th March 2022 - Dealings in Sabcap shares by prescribed officer

16th March 2022 - Salient features extracted from the audited preliminary summarized results

17th February 2022 - Updated trading Statement for the year ended 31 December 2021

03rd February 2022 - Proposed Investment in Ascendis Medical through APEX

27th January 2022 - Proposed Investment in ARB through MEH and Masimong

25th January 2022 - Investment Commitments to a subsidiary of Masimong Group Holdings

21st January 2022 - Changes to Sabcap Board

17th January 2022 - Preliminary Sabcap Trading Statement

08th December 2021 - Sabcap investment committee constituted

02nd December 2021 - Disclousure of significant holding of Sabcap ordinary shares

02nd December 2021 - Voluntary announcement- Sabcap vaccination policy

25th November 2021 - Voluntary announcement- Sabcap general repurchase of shares

23rd August 2021 - Dealings in Sabcap shares by director and prescribed officer

20th August 2021 - Salient features of the unaudited results

20th August 2021 - Unaudited Interim results

13th August 2021 - Trading Statement as at June 2021

13th July 2021 - Availability of BBBEE compliance report

1st July 2021 - Sabcap trading update and preliminary trading statement for the 6 months ended 30 June 2021

26th May 2021 - Voluntary announcement - Sabcap general repurchase of shares

24th May 2021 - Report on proceedings at the Annual general meeting

12th April 2021 - Dealings in Sabcap shares by an associate of a Director

8th April 2021 - Dealings in Sabcap shares by Director

31st March 2021 - No Change Statement and Notice of AGM

29th March 2021 - Dealings in Sabcap shares by prescribed officer

25th March 2021 - Salient features extracted from the audited preliminary summarized results

11th March 2021 - Trading Statement as at December 2020

4th February 2021 - Settlement by Sabvest Limited

6th January 2021 - In Memoriam: Philip Coutts-Trotter

10th November 2020 - Trading update and interim cash dividend declaration

28th October 2020 - Dealings in SABCAP shares by Prescribed Officer

15th October 2020 - Dealing in SABCAP shares by Executive Director

9th September 2020 - Salient features of the unaudited results

9th September 2020 - Unaudited Interim Results

27th August 2020 - SABCAP board

26th August 2020 - Updated Trading Statement ended 30 June 2020

24th August 2020 - SABCAP appoints deputy CFO

30th June 2020 - Changes to the SABCAP Board

29th June 2020 - Trading Statement ended 30 June 2020

25th June 2020 - Report on Proceedings at the General Meeting

23rd June 2020 - Finalization of SABCAP shares

27th May 2020 - Notice of General Meeting

12th May 2020 - Update to abridged Prospectus

27th May 2020 - Notice of Sabvest Capital General Meeting

25th June 2020 - Notice of Sabvest Capital General Meeting

28th February 2020 - Prospectus

SENS, Circulars and Notices Sabvest Limited

For SENS, Notices and Circulars relating to Sabvest Limited, please see www.sabvest.com